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schaemic stroke is currently the third leading cause of death in the Western world and the leading cause of acquired adult disability. 1 In Caucasians, occlusion of extra-or intracranial cerebral arteries by thromboembolic material can be demonstrated early after stroke onset in 80% of stroke patients 2 making thrombolysis a rational therapeutic choice. Intravenous tissue plasminogen activator (tPA) remains the only drug and route of administration approved in North America and Europe for acute stroke treatment based on the results of the NINDS tPA trials and is recommended in all disabling ischaemic stroke patients fulfilling the clinical criteria of the NINDS tPA study. 3 Other thrombolytic trials have produced neutral results. [4] [5] [6] These trials had a common methodological design, and enrolled patients with ischaemic stroke by excluding intracranial haemorrhage using computed tomography but did not use any form of neurovascular imaging to identify a large artery occlusion (either extra-or intracranial). In contrast, the ProLyse for Acute Cerebral Thromboembolism trial (PROACT-II) 7 randomised a more homogenous population of acute stroke patients with angiographically proven middle cerebral artery occlusions and demonstrated a positive result.
The reality is that a simpler approach relying on clinical parameters and non invasive technology may facilitate more appropriate and widespread use of thrombolysis. The three objectives of this study were: (1) to describe the frequency of magnetic resonance angiographic (MRA) flow signal abnormalities of the internal carotid artery and/or middle cerebral artery in an acute ischaemic stroke population with disabling deficits; (2) to define the probability of intracranial abnormality in the anterior circulation by a quantitative topographical scoring system, the Alberta Stroke Program Early CT Score (ASPECTS) 8 9 ; and (3) to determine the sensitivity and specificity of the hyperdense middle cerebral artery (HMCA)and ''dot'' signs using MRA as the gold standard. 10 11 We speculated that MRA would provide similar anatomical localisation to formal cerebral angiography, that the HMCA sign represented middle cerebral artery occlusion in the main stem of the artery, and the MCA ''dot'' sign would correlate with occlusion either in the distal portion of the middle cerebral artery or in the M2 branches. 12 
13

METHODS
The period of patient recruitment was from October 1999 to July 2001. The principal inclusion criterion for the study was acute disabling ischaemic stroke, measurable by the National Institute of Health Stroke Scale (NIHSS) score, within 6 h of onset. All patients sequentially had a CT brain scan within 6 h followed by MRI within 7 h of onset. Some patients who met accepted criteria were treated with intravenous thrombolysis and the ensuing MR study was performed while the tPA infusion was running. Information collected on subjects included: demographic details; an NIHSS score on initial presentation; time of symptom onset and time at each imaging procedure; and functional outcome at 3 months assessed by the modified Rankin scale (mRS). The mRS was evaluated by a nurse practitioner not involved with the initial individual patient care. Favourable outcome was defined as independence (mRS of 0-2). The study was approved by the local ethics committee, and was part of a study to compare CT with diffusion weighted imaging (DWI) in acute ischaemic stroke. 14 All CT scans were performed on fourth generation scanners and were considered to be optimal quality. The standard CT scan protocol was 5 mm slice thickness without contrast enhancement, 120 kV, 170 mA at 2 s, contrast favoured algorithm, inferior orbitomeatal baseline, filmed at appropriate window width and level setting of 80/40 Hounsfield units. 9 MR imaging was performed on a 3 T scanner (General Electric Medical Systems, Waukesha, WI) equipped with a standard head quadrature imaging coil and high-speed gradients. The rationale for using 3 T MRI rather than 1.5 T MRI is that the former has better signal to noise ratio. 15 The imaging sequences included sagittal T1-weighted, axial diffusion-weighted, and perfusion-weighted imaging, fluid attenuated inversion recovery (FLAIR) imaging, and axial multi-slab 3D time of flight MR angiography (MRA). The isotropic diffusion-weighted images were obtained using a single shot EPI (b = 1000 s/mm 2 , 19-5 mm thick slices). The imaging parameters for the conventional two-slab 3D TOF sequence were 24/3.3/15˚(TR/TE/flip angle), acquisition band with of 12.5 Hz, and a 2406192646 mm acquired volume with a 2566192642 matrix, which was then reconstructed to a 5126512684 matrix. Axial slabs were prescribed from approximately the level of the skull base to the circle of Willis.
Each axial imaging technique (that is, CT and MRI) was read independently by each of five readers, blinded to all clinical and patient information apart from side of stroke symptoms. The rationale for this was to make the imaging interpretation more clinically relevant. The images were read in the following order: baseline CT, FLAIR, and DWI followed by the follow up CT, FLAIR, and DWI. Each imaging modality/technique was interpreted in isolation of other modalities, with a minimum period of 1 week between readings of scans by the same individual.
Each axial CT image (CT) was scored using the Alberta Stroke Program Early CT Score (ASPECTS). 8 9 A normal CT scan received an ASPECTS of 10 points; a single point was subtracted for an area of ischaemic change as defined by von Kummer, 16 17 which included any or all parenchymal hypoattenuation, loss of grey white differentiation, and focal brain swelling. Parenchymal hypoattenuation was defined as a region of abnormally decreased attenuation of brain structures relative to attenuation of other parts of the same structures or of the contralateral hemisphere. Focal brain swelling was defined as any focal narrowing of the cerebrospinal fluid space due to compression by adjacent brain structures producing effacement of the cortical sulci or ventricular compression. A score of 0 indicated diffuse ischaemic involvement throughout the MCA territory. The 24 h CT scan was read under the same conditions.
The presence of an HMCA sign 10 and a sylvian fissure MCA ''dot'' sign 11 was assessed. The HMCA was defined as an MCA denser than its counterpart and any other vascular structure excluding obvious calcification. The MCA ''dot'' sign was defined as the hyperdensity of an arterial structure (seen as a dot) in the sylvian fissure relative to the contralateral side or to other vessels within the sylvian fissure.
The MR angiogram was assessed by a single expert reader blind to all information apart from stroke symptom side, firstly at baseline, and then at the follow up at 24 h. The reasons for using MRA as the preferred imaging modality were its non invasiveness, the avoidance of radiation contrast agents, and its superior accuracy compared to other non invasive vascular techniques such as transcranial Doppler.
For each non contrast examination the collapsed maximum intensity projection and source images were reviewed. The reader detailed the vascular abnormalities by the vascular signal intensity in the following extra-and intracranial vessels: the left and right internal carotid artery (ICA), the basilar artery (BA), the anterior cerebral arteries (ACAs), the left and right main stem of the middle cerebral artery segments (M1) and the MCA branch division (M2) regions of the MCA, and the left and right main posterior cerebral artery (PCA) segments.
STATISTICAL ANALYSIS
Data are reported using descriptive statistics. Baseline and follow up CT and DWI ASPECTS values were derived as the median of the results of the five observers. Comparisons of proportions, sensitivity and specificity, relative risks, and confidence intervals were assessed using 262 tables and exact methods. The presence of either M1 or M2 MRA flow signal abnormality was used to perform the sensitivity calculation. Logistic regression was used to adjust for baseline stroke severity in the assessment of the association between ASPECTS and arterial occlusion. Functional outcome was dichotomised into independence (mRS 0-2) and dependence or death (mRS 3-6).
RESULTS
A total of 100 consecutive patients were enrolled into the study, of whom 69% were male, and the mean (SD) age was 68 (13.9) years. The median NIHSS was 9 (interquartile range 3-16). A total of 39 patients received tPA: 33 patients received intravenous tPA alone, and six received a combined approach of intravenous tPA followed by intra-arterial thrombolysis into the angiographically defined thrombus. 18 Of the patients 60% were independent (modified Rankin score 0-2) at 3 months (two patients were lost to follow up at 3 months). There were nine deaths, of which two were due to tPA-related fatal intracerebral haemorrhages.
The median baseline CT ASPECTS was 8, which was the same as the median baseline DWI ASPECTS. A total of 67% (95% confidence interval (CI) 0.59 to 0.78) of the patients had CT ischaemic change (ASPECTS(9), while 79% (95% CI 0.70 to 0.87) of the DWI scans identified areas of hyperintense signal (DWI ASPECTS (9) . Six patients (6%) had evidence of posterior circulation ischaemia on baseline DWI with or without coincident anterior circulation stroke. The mean (SD) time from symptom onset to CT was 117 (70) min compared to 219 (80) min to MR imaging (a mean (SD) difference of 102 (51) min, p = 0.0002). On CT, there were 10 hyperdense MCA signs and 19 MCA ''dot'' signs (four patients had both hyperdense MCA and ''dot'' signs) (fig 1) . There were a total of 47 MRA flow signal abnormalities in the anterior circulation, of which 14 involved the ICA, either with M1 (five) or M2 (seven) alone, or both M1 and M2 (two). A total of 18 MRA abnormalities involved M1 (without ICA involvement), and 15 M2 MRA abnormalities (without involvement of either ICA or M1). The sensitivity and specificity of the hyperdense MCA and MCA ''dot'' sign are presented in table 1.
Both ASPECTS value ( fig 2) and baseline NIHSS score predicted the presence of an intra-or extracranial occlusion. The relative risk of an occlusion on 3D TOF with a baseline NIHSS>10 was 2.22 (95% CI 1.39 to 3.56). After adjusting for baseline stroke severity, for each decrement of one ASPECTS point, the odds of an occlusion involving the internal carotid artery, M1 or M2 branches rose 2.7 fold (95% CI 1.8 to 4.1). Alternately, when the baseline CT ASPECTS was less than or equal to 7, the probability of occlusion on subsequent MR angiography was 0.88 (95% CI 0.72 to 0.97) for a relative risk of occlusion of 3.27 (95% CI 2.2 to 5.0). No interaction was detected between ASPECTS value and baseline NIHSS score (likelihood ratio test, p = 0.70), meaning the ability of ASPECTS to predict the MRA flow signal abnormality is not dependent on the NIHSS score.
DISCUSSION
Neurovascular imaging can assist in the appropriate selection of stroke patients for thrombolysis. 19 Patients without occlusions receiving treatment with thrombolysis are possibly exposed to risk without obvious potential benefit. Results from the PROACT-II study suggest that, among patients with confirmed intracranial occlusion, the time window for useful intervention is longer than 3 h following the onset of symptoms.
In this cohort of consecutive patients stroke severity (median NIHSS 9) was not disimilar to that of patients enrolled in either the ECASS II or ATLANTIS B thrombolysis clinical trials. 4 5 Yet only 47% of cases in this study had demonstrable MRA flow signal abnormalities in the MCA vascular territory. The most striking observation from this study was that ASPECTS predicts MRA flow signal abnormality independently of the NIHSS score. As the ASPECTS value decreased the probability of an MRA flow signal abnormality increased such that all cases with an ASPECTS of 5 and below had an MRA flow abnormality. When the CT scan was normal (ASPECTS 10) the prevalence of MRA flow abnormality in the anterior circulation was small (11%). Both ASPECTS and NIHSS were independent predictors of occlusion, and therefore, may be important clinical indices in predicting vascular occlusion. The relationship between NIHSS and MRA flow signal abnormalities has been previously reported. 20 The HMCA sign has been associated with severe neurological deficit, extensive infarction in the MCA territory, and poor outcome 21 and correlates well with MCA occlusion based on angiography. 12 13 The recently described MCA ''dot'' sign 11 correlates with distal MCA occlusion identified by conventional angiography. We now report the sensitivity and specificity of these signs using 3D TOF MRA as the gold standard. In accordance with previous angiographic studies, 22 the sensitivity of both these signs is in the poor to moderate range, but both have very high specificity, confirming that when present they have a high positive predictive value for thromboembolic occlusion. MRA provides anatomical and physiological evidence of flow through the major collateral pathways, and allowed non invasive correlation of the CT vascular signs. Conventional angiography remains the gold standard for assessing the collateral pathways and is consistent with anatomical studies. 23 But the risk of inducing stroke in this particular patient group may be similar to or higher than the complication rate in the Asymptomatic Carotid Surgery Trial of 1%. 24 Time of flight angiography allows the arteries of the circle of Willis to be examined by the endogenous contrast of flow-related spin enhancement and a flow related abnormality can indicate either an absence of flow or slow flow. The rationale for the use of MRA as the gold standard was its safety (cf formal cerebral angiography), and avoidance of radiation and contrast bolus as with CTA. In addition its accuracy is probably superior to other techniques such as transcranial Doppler. 25 In a study comparing TOF MR angiography of carotid stenosis, flow void artefacts represent severe carotid stenosis when compared to formal angiography. 26 The major drawback of this method is the depiction of the distal intracranial vessels which may account for some of the under-reporting of distal MCA branch abnormalities in this study. 27 Previous data support the concept that stroke patients can be selected on the basis of stroke severity and quantified CT ischaemia. 4 6-8 28 29 There is mounting evidence that the extent of CT ischaemia is very important in determining response to therapy. In a post hoc analysis of ECASS I, 29 patients with signs of ischaemia involving (1/3 MCA benefited from tPA treatment when compared to placebo (OR 3.43, 95% CI 1.61 to 7.33). The benefit was less clear for patients with normal CT scans or parenchymal hypodensity involving .1/3 MCA, and did not exclude the possibility of harm.
These data combined with the current work support the idea of a therapeutic trichotomy in acute stroke patients: (1) the normal CT scan (low prevalence of middle cerebral artery occlusion) may indicate patients who will improve spontaneously; (2) the CT scan with early but not extensive ischaemic changes (ASPECTS 7-9; high prevalence of MCA occlusion) may indicate the ideal thrombolysis candidate; and (3) the CT scan with extensive CT ischaemic change (high prevalence of MCA occlusion) may indicate the patient least likely to benefit from thrombolysis. This stratification may change with time from stroke onset. Therefore, we propose that successful tPA adminstration for acute stroke depends on careful clinical assessment, combined with selection of patients with a CT scan showing moderate rather than extensive ischaemic change. This group of patients have a high probability of large artery occlusion with associated ''tissue at risk'', and therefore may benefit most from thrombolysis. This concept would require further validation before it impacts patient care but a systematic approach to the assessment of non contrast CT with ASPECTS may provide a useful surrogate in future thrombolysis trials.
New CT techniques such as CT angiography, CT perfusion, and post contrast and blood pool analysis are being increasingly evaluated in clinical practice: the latter has been shown to increase the visualisation of ischaemic areas by 40%. 30 However, the functional outcome following tPA administration is time dependent, 31 and additional contrast enhanced CT techniques, as with MRI, may delay initiation of treatment with no additional benefit. 
Case report
We report an 18 year old patient with right frontal lobe epilepsy due to paramedian focal cortical dysplasia (FCD). The patient's usual seizure semiology consisted of a somatosensory aura of the left hand followed by a tonic seizure of the left arm which evolved to a bilateral asymmetrical tonic seizure without loss of consciousness. In the two years preceding the study (see below) he had rare night-time seizures only. His antiepileptic medication consisted of levetiracetam 500 mg, phenobarbital 25 mg, and carbamazepine 1600 mg daily.
During presurgical videoelectroencephalogram (video-EEG) monitoring, interictal EEG showed right frontotemporal spikes. Ictal EEG revealed seizure patterns with a right frontal onset. Magnetic resonance imaging (MRI) showed FCD in the right superior frontal gyrus extending into the right precentral gyrus ( fig 1A) . Neurological examination was normal.
Transcranial magnetic stimulation
The patient participated in a TMS study using a protocol described previously 2 to evaluate intracortical excitability of both motor cortices (M1). The study was approved by the local ethics committee, and the patient gave written informed consent. We used a focal 70 mm figure of eight coil connected to two magnetic stimulators via a BiStim module (Magstim Company, Dyfed, UK). Surface electromyography (EMG) was recorded from the contralateral abductor digiti minimi muscle (ADM) of the hand.
TMS commenced over the left M1 contralateral to the epileptic focus with the coil placed over the M1 hand area. First, motor thresholds (RMT, AMT) and cortical induced silent period at an intensity of 110% RMT were evaluated. Next, paired pulse TMS (conditioning stimulus set at 38% of maximum stimulator output, second stimulus 60% of stimulator output) was started on the left M1 with a train of paired pulses with ISI 2, 3, 10, and 15 ms in a random order.
After 65 stimuli, the patient noticed that his habitual somatosensory aura of the left hand followed by myoclonic jerks of the left forearm (mainly biceps brachii muscle and forearm flexor muscles) was triggered by each stimulus, contralateral to the epileptogenic zone but ipsilateral to the cortical stimulation. The jerks were triggered by both single and paired stimuli at all ISI and rapidly involved both arms. These motor phenomena were different from the typical seizure semiology. EMG recordings of the ADM showed movement artefacts 63-75 ms after the MEP (fig 1B) . The TMS was immediately interrupted, which aborted the myoclonus at once.
The TMS data of the left hemisphere showed increased motor thresholds, prolonged cortical induced silent period, markedly decreased intracortical inhibition, and increased facilitation compared with 20 controls 2 (percentiles of the patient's measures within the control group: .99% for ISI 2 and CSP, .95% for motor thresholds and ISI 15, .90% for ISI 10, and .85% for ISI 3).
After the TMS experiment, the patient was again free of daytime seizures until the last follow up visit six months later.
Transcallosal seizure induction by paired pulse TMS
In patients with epilepsy, all reported cases of seizure induction by TMS have occurred during ipsilateral stimulation and near to the epileptic focus. Therefore, it has been assumed that direct stimulation of the epileptogenic tissue was required to trigger a seizure. 1 We used a focal coil placed over the left M1 hand area more than 5 cm away from the midline. Thus, it is unlikely that the right epileptogenic zone or mesial frontal cortex of the present patient was stimulated directly, and we assume that an indirect transcallosal activation of the epileptogenic zone provoked the aura. The latency of 65-75 ms of the myoclonic jerks after the MEP may reflect polysynaptic pathways in addition to a direct transcallosal connection of both M1. It is still not clear whether involvement of additional cortical areas such as the ipsilesional and contralesional sensory cortices or basal ganglia contributed to the seizure provocation. Despite the patient's statement that the jerks were not volitional, this cannot be completely ruled out. The preceding somatosensory aura, however, represented his typical seizure semiology. We hypothesise that transcallosal activation of the epileptic focus was promoted by the increased excitability of M1, which was due to the underlying FCD. This, in turn, led to the aura and peri-ictal changes in M1 excitability facilitating TMS driven myoclonic jerking. It has been previously reported that FCD is intrinsically epileptogenic and promotes reflex seizures. 3 There is a possibility that ipsilateral pathways of movement activation could underlie our observations. In a child with extensive cortical dysplasia, TMS of the unaffected hemisphere evoked MEPs in both ADM muscles implying bilateral corticospinal connections from one cortex. 4 Histological studies on severe brain damage in early development have revealed collateral sprouting into denervated areas of cortex or spinal cord. 4 Ipsilateral activation under maximum muscle contraction has been observed in healthy volunteers and in patients with acute stroke. 5 Our patient, however, presumably had congenital but circumscribed FCD, no motor deficits, and was investigated at rest. This and the fact that his habitual somatosensory aura occurred before the myoclonic jerks strongly argue against the activation of ipsilateral corticospinal tracts. Activation of a silent mirror focus in the left hemisphere with subsequent spread to the right is also unlikely because exclusively right sided ictal and interictal epileptiform discharges were recorded during the video-EEG monitoring.
Changes in motor cortex excitability
Our patient's higher motor thresholds compared with controls are very likely due to his ion channel blocking anticonvulsant medication. ........................................................................................ 
....
The loss of intracortical inhibition and increased intracortical facilitation in the left hemisphere contralateral to the epileptogenic zone may reflect synaptic reorganisation of the ipsilesional and contralesional motor cortices. These distant functional cortical changes associated with malformations of cortical development have also been described previously. 7 The prolongation of the cortical induced silent period seen in the present patient may be independent of the phenobarbital intake 6 and confirms similar findings from previous studies as a remote effect of FCD on the motor cortex in untreated patients with cortical dysgenesis. 7 
Conclusion
Unilateral epileptogenic FCD involving M1 can induce complex bilateral alteration of motor cortex excitability resulting in a net increase of excitability. In such cases, transcallosal seizure induction appears to be possible with paired pulse TMS using a focal coil away from the epileptic focus. During the next 14 years, the patient was admitted on several occasions with episodes of confusion and agitation: investigations including lumbar puncture, CT scans, EEG, thyroid function, porphyria screens, autoantibody screens (including antinuclear antibodies, ANCA, and those against extractable nuclear antigens), and metabolic and septic screens were found to be normal. She had been admitted to the psychiatry unit and was thought to be suffering from acute mania or a dissociative state, precipitated by stress and sleep deprivation. In 2001, she was referred to the neurology clinic for similar episodes, which were increasing in frequency.
On first review in the neurology clinic, clinical examination was unremarkable except for bilaterally symmetrical and brisk reflexes. MRI scan of the brain and EEG were repeated and found to be normal. Thyroid peroxidase antibody was raised at 250 IU/ml (normal range 0-60). Thyroid function tests were normal.
She remained well until April 2003 when a further episode of drowsiness and confusion occurred (thyroid peroxidase antibody 266 IU/ml). This responded remarkably and within 24 h to a course of dexamethasone given intravenously at a dose of 16 mg daily for 5 days. An EEG repeated during the episode showed diffuse slowing but no epileptiform abnormalities.
The patient was re-admitted in May 2004 with another episode of confusion and agitation. Interestingly, this episode occurred after a 5 day course of oral prednisolone 60 mg/day for a chest infection. Apart from the acute confusional state there was no focal neurology. Repeat CT scan and CSF examination including oligoclonal bands were within normal limits. Repeat thyroid peroxidase antibody was elevated at 272 IU/ml (normal range 0-60). Voltage gated potassium channel antibodies were negative. Other investigations including thyroid function remained normal. EEG showed diffuse bilateral slow wave activity. A 7 day course of intravenous dexamethasone 16 mg/day was initiated. The confusion and agitation worsened and later she became very drowsy. Intravenous immunoglobulin (400 mg/kg daily) was given causing a dramatic improvement within 12 h. Unfortunately, on the same day, the patient developed an increase in alanine transaminase and C-reactive protein levels. A possible reaction to intravenous immunoglobulin was considered and the infusion was discontinued. Later, the increased levels were confirmed to be secondary to septicaemia from a Staphylococcus aureus infected cannula site. The inflammatory markers normalised after a course of antibiotics. During this time the patient remained drowsy, confused, and occasionally agitated. A 5 day course of intravenous immunoglobulin was reinstated. Again, there was a dramatic improvement within 24 h and she was discharged home at the end of the course having completely recovered.
Discussion
Hashimoto's encephalopathy (HE) is a steroid responsive disorder characterised by high titres of anti-thyroid antibodies. The original description of this condition was in an established case of Hashimoto's thyroiditis where the patient developed focal neurological deficits and coma. 1 Clinical presentation includes episodic confusion, myoclonus, seizures, and stroke-like episodes. 2 Females are more affected than males (3.6:1), with a mean age of onset of 41 years. The hallmark of HE is its response to steroids, most cases improving within a few hours to days. 3 The titres of anti-thyroid antibodies maybe independent of the severity of the clinical presentation. 4 Fewer than 100 cases of HE have been reported in the literature. Goitre and hypothyroidism can be associated with the disorder, but the majority of patients are euthyroid. Although steroid responsiveness is the rule, additional immunosuppressive therapy in the form of azathioprine and cyclophosphamide has been tried in a minority of patients. 2 3 One case report of HE responding to plasmapheresis is documented. 5 There was no benefit in the two documented cases where intravenous immunoglobulin was administered. 5 6 Several pathophysiological hypotheses have been suggested for HE. The initial report of HE suggested a vascular aetiology followed by localised cerebral oedema as a possible mechanism.
1 Some authors suggest that the CSF thyroid autoantibodies may react with a putative CNS antigen and form immune complexes. 2 4 The immunopathological basis of this syndrome has been compared to a relapsing form of acute disseminated encephalomyelitis. 7 Although reversible MRI findings have been described in HE, 8 neuroimaging (except for isolated patchy uptake by isotope scans) is usually normal in most cases. 3 Cerebral angiography has been found to be normal in several cases of HE, unlike in many other cerebral vasculitides. 1-3 5 Thyroid autoantibodies can co-exist with several other forms of autoimmune encephalomenigitis, but the normal MRI scan, the initial dramatic response to steroids, and negative autoantibodies for most other common vasculitides, tends to favour the diagnosis of HE in our case. Steroid responsive encephalopathy associated with Hashimoto's thyroiditis is an alternately proposed name for this condition, 9 but the vast majority of cases have normal thyroid function, leaving ''Hashimoto's encephalopathy'' a universally accepted term. A recent literature review of 85 patients with encephalopathy and antithyroid antibodies suggests that the combination of encephalopathy, high serum anti-thyroid antibody concentrations, and
Competing interests: none declared responsiveness to glucocorticoid therapy seems unlikely to be due to chance. 10 The initial meningo-encephalitic type presentation of our patient in 1987 was probably the first manifestation of HE in view of clinical findings and laboratory data (Mild CSF pleocytosis is not unusual in HE. 3 ) There was a delay of 14 years before the diagnosis was first established, in spite of several hospital admissions. The initial relapses after diagnosis responded well to steroids, confirming the diagnosis of HE. Whether the current episode was precipitated by the sudden withdrawal of oral steroids or the chest infection itself, for which they were prescribed, is unclear.
Our patient illustrates the possibility of steroid resistance in an established case of HE and the need to consider further immunomodulatory therapy. Intravenous immunoglobulins are a safe, convenient, and effective treatment in such circumstances.
Spontaneous lobar haemorrhage in CADASIL
CADASIL is an autosomal dominant form of arteriopathy, primarily affecting cerebral vessels, and predominantly caused by point mutations in the Notch3 gene on the short arm of chromosome 19.
1 Affected individuals develop subcortical strokes and cognitive deficits in their 50s and 60s. 2 Brain magnetic resonance imaging (MRI) shows large areas of leukoencephalopathy and multiple subcortical lacunar infarcts. Small arteries and capillaries are characterised histologically by a non-atherosclerotic, non-amyloid angiopathy with accumulation of granular osmiophilic material (GOM) within the smooth muscle cell basement membranes and extracellular matrix. 3 While CADASIL is considered a primarily ischaemic form of vascular dementia, microhaemorrhages have recently been reported in 31% of symptomatic Notch3 mutation carriers, suggesting that structural fragility of the arterial walls may lead to leaking of haem products. 4 Lobar haemorrhage in the absence of other risk factors for haemorrhage has previously been reported in one patient with CADASIL. 5 Here we report a second case.
Case report
A 56 year old man who had been diagnosed with multiple sclerosis six years earlier was admitted to the hospital with an acute change in mental state. He had collapsed at home and was unresponsive when rescue arrived. In the emergency room he had a depressed level of consciousness and difficulty following commands, with paucity of speech, dysarthria, and hypophonia. There was no evidence of head trauma. His blood pressure was 100/63 mm Hg and his temperature was 36.1˚C.
Past medical history included chronic obstructive pulmonary disease, prostate resection for prostate cancer, and a history of nicotine and alcohol dependence. He had no history of hypertension, diabetes mellitus, or coagulopathy. His drug treatment included ipratropium, ranitidine, methyprednisolone, and albuterol. His mother, now deceased, had been diagnosed as having multiple sclerosis and had migraines with auras, stroke-like symptoms, and dementia. He had eight siblings, three with headaches and one with recent transient ischaemic events.
Computed tomography (CT) of the head in the emergency department showed an area of high attenuation in the right frontal lobe consistent with an acute intraparenchymal haemorrhage ( fig 1A) . There was no evidence of trauma on head CT. Gradient echo MRI sequences of the brain done on hospital day 2 showed a 262.5 cm area of haemorrhage in the superior-anterior aspect of the right frontal lobe white matter as well as a microhaemorrhage in the right parietal region ( fig 1B) . The area of haemorrhage was hypointense on T2 ( fig 1C) and isointense on T1 weighted sequences (fig 1D) , consistent with acute haemorrhage. There was no MRI evidence of a cavernous haemangioma, arteriovenous malformation, or tumour. Magnetic resonance angiography was not done. A brain biopsy of the right frontal lobe done on the seventh hospital day showed degeneration of small and medium sized arteries. Vessel walls were thick and hyalinised in the grey matter, white matter, and meninges. PAS staining was positive and the muscular coat of the large vessels revealed degenerative changes. Electron microscopy showed the granular osmiophilic material characteristic of CADASIL. Notch3 gene testing revealed a R133C mutation in exon 4, consistent with the diagnosis of CADASIL. The patient remained normotensive throughout his hospital stay. On the fifth hospital day he developed aspiration pneumonia requiring mechanical ventilation. He died eight days later as a result of this pneumonia.
Comment
This is the second report of spontaneous cerebral haemorrhage in a patient with CADASIL. In 1977, Sourander and Walinder reported a 29 year old man with hereditary multi-infarct dementia on anticoagulants, with a large haemorrhage in the right hemisphere. 5 This family was thought to be one of the first with CADASIL; however, recent testing for Notch3 mutations in the family has not confirmed that diagnosis. 6 In 1992, Baudrimont et al reported a case of massive left cerebral haematoma involving the caudate nucleus, internal capsule, and thalamus in a 40 year old normotensive woman who was a member of a large CADASIL family. She had no known history of other risk factors for haemorrhage. 7 The index patient in this report had no evidence of coagulopathy and no history of previous hypertension, cerebral haemorrhage, or anticoagulant therapy. The patient could have experienced a haemorrhagic contusion related to a closed head injury during his unwitnessed fall before admission, but there was no evidence of trauma on physical examination or on head CT. On MRI there was no evidence of a cavernous haemangioma, arteriovenous malformation, or neoplasm. Necropsy was not carried out.
Ultrastructural analysis of small arteries in human postmortem brain and skin in patients with CADASIL shows breakdown of the arterial wall cytoarchitecture, which may help explain the propensity for microhaemorrhages. 8 The first notch3 transgenic mouse shows early widening of the subendothelial and intra-smooth-muscle spaces in the vascular smooth muscle cells, denoting weakening of the arterial wall and increasing susceptibility to micro-and macrohaemorrhages. 9 This case report supports the growing evidence for both ischaemia and haemorrhage in a variety of small artery diseases including amyloid angiopathy and CADASIL. 10 11 Clinicians may need to consider the possibility of haemorrhage when evaluating new events and deciding on treatment for stroke prevention in patients with CADASIL.
Urinary retention caused by a small cortical infarction
The cortical representation of micturition is speculated to reside in the medial frontal lobes. 1 2 Lesion pathology, however, varies from acute stroke to a neoplasm, and there is not necessarily a small, distinct lesion. 2 We report a case of urinary retention in which the main presenting symptom is thought to have been caused by a small cortical infarction.
Case report
One morning, a 66 year old, right handed man had difficulty urinating. He had no history of voiding difficulty, diabetes mellitus, injury to the lower urinary tract, or neurological disease. Digital rectal examination and ultrasonography of the prostate detected no enlargement. Urinalysis showed no haematuria or pyuria. He was not taking any medications that cause voiding dysfunction. There was no urinary incontinence, but he had difficulty in voiding even though he felt the bladder was full. At that time, he also had difficulty in lifting his left arm and leg and so was brought to our hospital. Neurological examination in the emergency room found no weakness, and he was sent home. Later, he experienced urinary retention and visited the emergency room again. His post void residual urine volume was 350 ml, and an urinary catheter was inserted. At that time the patient was alert, and his cranial nerves were intact. Limb muscle strength was normal. Sensory examination was unremarkable. Tendon reflexes were normal in all four limbs. Tandem gait and standing on one foot were difficult. He had normal bladder sensation but difficulty in urinating. Drip infusion pyelography revealed no abnormality in the upper urinary tract or the form of the bladder. Filling cystometry showed stable detrusor with normal bladder sensation, whereas acontractile detrusor was noted in the voiding phase. He could void only with strain, having a peak flow rate of 5.0 ml/s and a voided volume of 135 ml. Diffusion weighted MRI, performed on the day of onset, showed a small, distinct, high intensity signal, and T1 weighted imaging showed a low signal in the right caudal part of the anterior cingulate gyrus, indicative of an infarct in the acute stage ( fig 1A and C) . No definitive infarct was observed elsewhere. MR angiography showed no occlusion or stenosis of the intracranial vessels. An electrocardiogram was normal. Transthoracic echocardiograms showed no abnormal findings. The urinary catheter was withdrawn 3 days after admission, and he had no subsequent difficulty with urination. His gait returned to normal about the same time.
Discussion
In the acute stage of a cerebral vascular accident, the presenting symptom often is urinary retention due to detrusor areflexia, 3 but patients who have this problem usually have a major stroke with severe neurological deficits.
To the best of our knowledge, this is the first report in the English literature of urinary retention, although temporary, caused by a small cortical infarct as shown by diffusion weighted MRI.
Various cortical areas are activated during voiding because a network of brain regions is necessary for voiding modulation. 4 The locations of the primary cerebrum cortical areas for voiding and storage are speculated to be separate, the former being at the para-central lobule. 2 A PET study found normal micturition to be associated with activation of the middle frontal gyrus, superior frontal gyrus, superior precentral gyrus, thalamus, and the caudal part of the anterior cingulate gyrus in the left hemisphere. 5 Another recent PET study showed that increased brain activity related to increasing bladder volume was located in the bilaterally mid-cingulate cortex, while that related to decreased urge to
